Answers are grounded in this paper and cite their sources.
Dear Editor Diabetes and its effects have a significant financial impact on the world and it exhausts the economies of countries and will only get worse by 2030. Even if nations achieve their collective goals, the economic load on the world would not lessen [1]. AI such as machine learning (ML) or deep learning is growing dramatically in many subjects of life and increasing speedily in medical aspects and especially in discovering diseases and medical equipment in diabetes such as insulin pumps and continuous glucose monitoring (CGM) with sensors [2]. Noncompliance with suggested treatment has delayed the onset of long-term problems, which can take years. As a result, diabetes management is complex, and therapeutic decisions must consider various medical aspects as well as lifestyle-related activities that must be adjusted to improve the quality of life of diabetic patients. Artificial intelligence (AI) is a rapidly expanding area, and its applications to diabetes research are expanding even faster [3]. Diabetes does not affect just the patient but all families as need multidisciplinary care and need health education and follow-up with health-care providers to update the health condition and follow-up from complications so using the ML model will help with health education and suspect complications [4]. Using CGMs helps diabetics patients with type I diabetes to improve control and avoid hypoglycemia occurrence and avoid the frequent bricking of the skin, AI in large diabetic databases that integrate different data sources are rapidly necessitating the use of AI approaches for the creation of applications for therapy personalization and complication prevention [5]. The most challenge in diabetes management and during aerobic exercises is the occurrence of hypoglycemia so the use of AI can be giving promising role in the prevention of hypoglycemia a study by Vehí et al. introduced the patient safety system, an AI-based decision support system for the prediction and prevention of hypoglycemia events and the classification of glycemic control profiles [6]. Time in the range is very important and is considered an eye on controlling blood glucose all day. It collects blood sugar measurements from the CGM every 5 min and analyzes them in real-time using AI algorithms. Incorporating AI into future products successfully will help Medtronic fulfill its aim of employing biomedical engineering to restore health and minimize the management load for individuals with diabetes. Moreover, widen the use of time in the range using AI in CGM devices[5]. Nowadays and after more, many drugs are growing dramatically and will see hundreds of medicines and many anti-diabetic groups and many updated guidelines, and many insulin in the next year’s many groups of medications for diabetes so choosing the best suitable type of patient need more concentration and attention from doctors. Finally, AI may play a very important role in the next years to help doctors to speed up the decision for choosing the right medicines for patients using ML such as the medical history, drug history, contraindications, updated guidelines, A1C, laboratory investigations, type of diabetes, risk of hypoglycemia, drug interactions, alarming when blood glucose drop and warning signals, and helping doctors at giving correct decision for fasting for patients at Ramadan and much helpful information. Furthermore, AI helps doctors at the decision at choosing the right type of insulin. Policy-makers must move quickly to equip health and social security institutions to deal with the effects of diabetes, fasten the use of AI in health education and control of diabetes, and improve outcomes using many learning machine models. Financial support and sponsorship Not applicable. Conflict of interests No conflict of interests declared.
No takes yet. Share an insight, caveat, or question.
Amr Ahmed (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: